C
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell and tissue replacement therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.
Investor insights
Funding rounds participated in
$25M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2017
Funding rounds raised
Total raised
$25M
from 1 investors over 1 rounds
C
Cellino raised $25M on October 10, 2024
Investors: Advanced Research Projects Agency for Health